Receptor dimerization is ubiquitous to the action of all receptor tyrosine kinases, and in the case of dimeric ligands, such as the stem cell factor (SCF), it was attributed to ligand bivalency. However, by using a dimerization-inhibitory monoclonal antibody to the SCF receptor, we confined a putative dimerization site to the nonstandard fourth immunoglobulin-like domain of the receptor. Deletion of this domain not only abolished ligand-induced dimerization and completely inhibited signal transduction, but also provided insights into the mechanism of the coupling of ligand binding to dimer formation. These results identify an intrinsic receptor dimerization site and suggest that similar sites may exist in other receptors.
Introduction
Receptor dimerization has been extensively studied in the family of transmembrane tyrosine kinases, the common catalytic activity of which is stimulated by binding of a ligand to the variable extracellular domain (UIIrich and Schlessinger, 1990) . Almost invariably, all of the tyrosine kinase receptors transverse the pla:sma membrane only once, and their transmembrane stretches display no conserved structural motifs, except for high hydrophobicity. This raised the possibility that signal transduction may involve intermolecular rather than intramolecular interactions. Studies performed with an isolated receptor for the epidermal growth factor (EGF) supported this model as they demonstrated that ligand binding was followed by rapid, but reversible, dimerization of occupied receptors and a concomitant increase in autophosphorylation (Yarden and Schlessinger, 1987) . In living cells, EGF receptors, as well as the receptors for colony-stimulating factor 1 (CSF-1) and platelet-derived growth factor (PDGF), undergo dimerization that can be demonstrated by the use of covalent cross-linking reagents (Bishayee et al., 1989; Cochet et al., 1988; Li and Stanley, 1991) .
An oligomerization activation model is indirectly supported also by in vivo lines of evidence. For example, a carcinogen-induced point mutation within the single transmembrane domain activates the tyrosine kinase function of the neu-encoded receptor and renders the protein oncogenic, probably through constitutive dimerization (Weiner et al., 1989) . Likewise, heterodimer formation between highly homologous receptors, such as the EGF receptor and the Neu protein, and the (~ and 13 forms of the PDGF receptor is probably responsible for the observed increases in ligand binding affinities, tyrosine phosphorylation, and biological activities (Goldman et al., 1990; Hammacher et al., 1989; Wada et al., 1990) . Lastly, the genetic phenomenon of dominance of certain mutant alleles of receptor tyrosine kinases in heterozygous animals is best explained by the formation of signaling-defective dimers comprised of wild-type and mutant receptors (Kashles et al., 1991; Nocka et al., 1990; Reith et al., 1990) .
Despite these in vitro and in vivo lines of evidence, the molecular mechanisms that underlie the process of receptor dimerization are still largely unknown. In the case of dimeric ligands, receptor dimerization has been attributed to bivalent ligand binding (Williams, 1989) , but dimerization by monovalent ligands, such as EGF, may require alternative mechanisms. To address some of these open questions, we selected the system of the c-kit-encoded receptor and its cognate ligand, the stem cell factor (SCF). Natural rodent mutants of both SCF and its receptor are defective in gametogenesis, melanogenesis, and erythropoiesis (Besmer, 1991) . As expected, Kit undergoes extensive dimerization upon binding of SCF (Blume-Jensen et al., 1991 ; Lev et al., 1992b) . Dimer formation, however, appears to be independent of the bivalency of the dimeric ligand since no dissociation of the dimers was observed at a large excess of SCF. In addition, the human ligand promoted heterodimer formation between the human and the murine receptors, despite the lack of ligand binding to the rodent Kit (Lev et al., 1992b) . These and other lines of evidence led us to propose that a receptor site, which is distinct from the ligand-binding pocket, stabilizes ligandinduced dimers of Kit (Lev et al., 1992b) . The extracellular portio n of Kit/SCF receptor includes five immunoglobulinlike domains, of which the three N-terminal domains comprise the ligand-binding site Lev et al., 1993) , but the function of the fourth and fifth domains remained unknown. In an effort to localize the putative dimerization site, we constructed and expressed in mammalian cells the whole extracellular domain of Kit. The soluble ectodomain not only bound SCF with high affinity but also underwent efficient dimerization (Lev et al., 1992c) . This implied that the putative dimerization site is confined to the extracellular portion of Kit. In the present study, we attempted to localize the hypothetical liganddependent dimerization site by employing a monoclonal antibody (MAb) and deletion mutants of the ectodomain Following 2 hr at 4°C, the cells were washed, and the ligand-receptor complexes were covalently cross-linked by a 40 min incubation at 22°C with 15 mM EDAC. Cell lysates were then prepared and directly subjected to electrophoresis on 50/0 SDS-PAGE. Autoradiography of the dried gels was for 24 hr at -70°C with an intensifier screen. The locations of molecular mass marker proteins are indicated by bars, and the corresponding masses are given in kilodaltons. Receptor monomers (M) and dimers (D) are indicated by arrows.
(B) Covalent complexes of radiolabeled SCF and Kit were prepared in the absence of MAbs as described above. Cell lysates were then prepared and subjected to immunoprecipitation with the indicated MAbs to Kit. The immune complexes were analyzed by electrophoresis on 5% SDS-PAGE and autoradiography.
of Kit. Using these molecular tools, we mapped the dimerization site to the fourth immunoglobulin-like domain of Kit.
In addition, inhibition of receptor dimerization by means of a MAb or through the use of the domain 4-deleted receptor allowed us to determine the functional consequences of the dimerization process and indicated that it is driven by a slower rate of release of the ligand from receptor dimers as compared with receptor monomers.
Results

An Anti-Kit MAb that Inhibits Receptor Dimerization
We have previously reported that a recombinant whole extracellular domain of Kit fully retained two functions of the wild-type receptor: high affinity binding of SCF and ligand-induced receptor dimerization (Lev et al., 1992c) . To identify the structures that undedie these two molecular functions of Kit, we raised a panel of MAbs by immunizing mice with the recombinant human ectodomain (denoted Kit-X). Whereas some MAbs completely inhibited SCF binding and thereby enabled immunological mapping of the ligand-binding site, other MAbs exerted only limited or no effect on ligand binding . MAbs that belong to the latter group were therefore examined in respect to their effect on ligand-dependent dimerization of Kit and their capacity to recognize receptor dimers. Two MAbs, designated K27 and K69, were found to inhibit selectively cross-linking of radiolabeled SCF to the dimeric form of the receptor in living cells (Figure 1 ). The effect of MAb K27 was concentration dependent; an almost complete disappearance of the cross-linked dimer was observed upon coincubation of cells that overexpress Kit with a radiolabeled SCF and saturating concentrations of the MAb. In contrast with the effect of K27, antibody K44, which interacted with the ligand-binding site , inhibited cross-linking of SCFto both monomers and dimers of Kit, whereas a third antibody, K45, displayed neither effect ( Figure 1A ). Other experiments that are not presented here indicated that the effect of MAb K27 was independent of its bivalency because a monovalent fragment of the antibody (denoted Fab-K27) also inhibited cross-linking of SCF to receptor dimers. Consistent with the capacity of MAb K27 to selectively inhibit the formation of complexes between SCF and Kit dimers, this antibody was unable to recognize preformed dimeric complexes; whereas both monomeric and dimeric complexes of Kit and radiolabeled SCF were recognized by MAbs K45 and K49, only the monomeric Kit-SCF complex was immunoprecipitable by MAb K27 ( Figure 1B ). By contrast, MAbs that recognized the ligand-binding site (i.e., K44, K57, and K58) precipitated neither form of the receptor. Based on the results that are depicted in Figure 1 , it was concluded that MAb K27 interacts with a site of Kit that is involved in receptor dimerization and the accessibility of which is masked within dimers of Kit.
The Putative DimerizaUon Site Maps to the Fourth
Immunoglobulin-like Domain of Kit The inability of the murine K27 antibody to recognize the routine Kit protein was exploited while attempting to confine the antigenic epitope of MAb K27 to 1 of the 5 immunoglobulin-like domains of Kit. A chimeric human Kit protein, whose three N-terminal immunoglobulin-like domains were replaced with the corresponding portion of the murine receptor, has been previously described and has been denoted HM-123 ( Figure 2a ). This protein was recognized by MAb K27 (data not shown), indicating that the antibody recognized the fourth or the fifth immunoglobulin-like domain. To confine further the putative dimerization site to a single immunoglobulin-like domain, we utilized a series of soluble Kit proteins that were constructed by introducing stop codons distally to the second, third, and fourth immunoglobulin-like domains. These soluble proteins, designated Kit 1-2, Kit 1-2-3, and Kit 1-2-3-4, respectively (Figure 2a ), were_expressed in Chinese hamster ovary (CHO) cells and were harvested from the respective conditioned media. Immunoprecipitation analysis indicated that a soluble protein that contained all of the four N-terminal immu noglobulin-like domains (Kit 1-2-3-4) was recognized by MAb K27, but deletion of the fourth domain or both the third and the fourth structural units abolished interaction with the MAb (Figure 2b mutant of the transmembrane receptor that lacked this structure. The deletion mutant, denoted A4 (Figure 2a ), was stably expressed in murine 3T3 fibroblasts. Although this protein was recognized by MAbs K44 and K45, the dimerization-inhibitory MAb K27 was unable to interact with it ( Figure 2c ). Taken together, the results shown in Figure 2 indicated that the fourth immunoglobulin-like domain of Kit includes the antigenic site of MAb K27, which, by inference, functions as a Iigand-dependent dimerization site.
Ligand-lnduced Dimerization of Soluble and Membrane Forms of Kit Depends on the Presence of the Fourth Immunoglobulin-like Domain
We next examined the coincidence of the putative dimerization site of Kit with the epitope of MAb K27 by performing a dimerization assay of soluble Kit proteins. As reported previously (Lev et al., 1992c) , incubation of the whole soluble ectodomain of Kit with SCF in the presence of a bifunctional covalent cross-linking reagent resulted in the appearance of receptor dimers in SDS-polyacrylamide gel electrophoresis (SDS-PAGE) ( Figure 3A ). By contrast, under the same conditions, a truncation mutant that contained only the three N-terminal immunoglobulinlike domains underwent no SCF-dependent dimerization ( Figure 3A ). Consistent with the possibility that the fourth immunoglobulin-like domain contains a dimerization site, its presence conferred to a soluble Kit protein, which contained all of the four N-terminal immunoglobulin-like domains (namely, Kit 1-2-3-4), the abilityto undergo dimerization in the presence of SCF ( Figure 3A ). Dimerization assays that were performed with transmembrane forms of Kit and a radiolabeled SCF further supported the possibility that the fourth immunoglobulin-like domain is necessary for SCF-induced receptor dimerization; unlike the full-length Kit protein that displayed both dimers and monomers in the presence of SCF, only monomers of the A4 mutant were observed in living cells ( Figure 3B ). Ligand binding to either protein could be abolished by MAb K44, but MAb K27 inhibited receptor dimerization with no effect on SCF binding to the monomeric forms of Kit ( Figure 3B ). To examine alternative explanations for the inability of Kit 1-2-3 to form dimers (namely, differences in affinities for ligand binding or differences in the ability to become covalently linked by the cross-linker), we compared the binding affinities of Kit-X, Kit 1-2-3-4, and Kit 1-2-3 by using ligand displacement and Scatchard analyses, and we found that they were very similar (KD = 1-2 nM; data not shown). In addition, the molecular weights of Kit-SCF complexes were determined in the absence of crosslinking reagent by using native gel electrophoresis (Amster-Choder and Wright, 1992). The technique is based (44) were incubated for 2 hr at4°C with 2 nM 1251-SCF in the presence of 10 pg/ ml of the indicated MAb or with no antibody. The cross-linking reagent EDAC was then added to 15 mM final concentration, and the incubation was continued for 40 min at 22°C. Covalent complexes of radiolabeled upon the observation that increasing gel concentrations affect the migration of larger proteins more than smaller proteins. Kit-X and Kit 1-2-3 were incubated with radiolabeled SCF in the absence of a cross-linking reagent and were then resolved by electrophoresis through a series of gels that differed in their acrylamide concentrations ( 5 % -9%; Figure 3C shows an example of a 8.5% gel). A function of the relative mobility of each radio!abeled complex, as well as the mobilities of standard proteins, was then plotted versus the concentration of acrylamide to construct Ferguson plots (data not shown). The slope of each plot yielded a retardation coefficient the logarithm of which was then plotted against the logarithm of the relevant molecular weight range (Figu re 3D). By extrapolation of their retardation coefficients, the native molecular weights of the two species of Kit-X were 130 kDa and 240 kDa, whereas the single Kit 1-2-3 species corresponded to 90 kDa (Figure 3D) . This analysis confirmed that Kit-X-SCF complexes exist as monomers and dimers in solution, but the respective complex of Kit 1-2-3 is present only in a monomeric form.
The Fourth Immunoglobulin-like Domain Enables Coupling of Ligand Binding to Kinase Activation
The availability of a dimerization-inhibitory MAb to Kit and a receptor mutant with defective dimerization enabled us to address the necessity of receptor dimerization for signal transduction. This question was first analyzed in relation to stimulation of the intrinsic tyrosine kinase activity of Kit. Preincubation of Kit-expressing cells with MAb K27, but not with other MAbs that do not affect receptor dimefization, inhibited tyrosine autophosphorylation of Kit ( Figure  4A ). The effect was concentration dependent, and it was displayed also by the dimerization-inhibitory monovalent fragment of MAb K27 ( Figure 4B ). Consistent with an interpretation that receptor dimerization is essential for kinase activation, SCF at concentrations as high as 500 ng/ml was unable to elevate tyrosine phosphorylation of the dimerization-defective mutant of Kit, namely A4. By contrast, significant stimulation was observed in cells express-SCF and Kit proteins were then analyzed by immunoprecipitation with an anti-Kit-X rabbit antiserum, followed by SDS-PAGE (6% acrylamide) and autoradiography.
(C) Purified Kit-X (1 p~g) or Kit 1-2-3 (1 pg) was incubated for 2 hr at 22°C with radiolabeled SCF in the presence (plus Sign) or absence (minus sign) of BS 3 (0.5 mM) and was then subjected to native gel electrophoresis (8.5% acrylamide) in the absence of SDS. . SCF (100 ng/ml) was then added to some of the monolayers (labeled with a plus sign), and the incubation was continued for 10 min at 37°C. Cell lysates were then prepared in the presence of phosphatase inhibitors, and the Kit protein was subjected to immunoprecipitation with a polyclonal rabbit antibody (IP Ab) to Kit-X. The immunocomplexes were resolved by gel electrophoresis and transferred onto nitrocellulose filters that were blotted with a MAb to phosphotyrosine (PY20) and detected by chemiluminescence. The final concentrations of Fab-K27 and K44, unless indicated, were 5 #g/ml and 1 p.g/ml, respectively. Minus sign, no SCF added; Mr, relative molecular weight. (C) Murine fibroblasts that overexpressed fulNength Kit (wt) or a protein that lacked the fourth immunoglobulin-like domain (A4) was incubated for 10 min at 37°C in the absence (minus sign) or presence (plus sign) of SCF (100 ng/ml). Cell lysates were then prepared, and the Kit proteins were immunoprecipitated with an antibody (IP Ab) to the C-terminal tail (212). The immunocomplexes were resolved by gel electrophoresis, which was followed by immunoblotting (IB) with either an antibody to phosphotyrosine (PY20 [ICN Biochemicals]) or an antibody to Kit (anti-Kit-X).
ing the wild-type receptor (Figu re 4C). Control experiments that involved Western blotting ( Figure 4C ) and in vitro kinase assays (data not shown) excluded the possibility that the differential effect was due to loss of expression of A4 or inactivation of its catalytic function, respectively.
Receptor Dimerization Is Essential for Short-and Long-Term Effects of the SCF
It was predictable that inhibition of kinase activation through interference with receptor dimerization will inhibit all downstream signaling events that are elicited by SCF. As a short-term effect, we selected the interaction of ligand-stimulated Kit with the intracellular enzyme phosphatidylinositol 3'-kinase (PI3K) (Lev et al., 1992a) . Unlike the ligand-stimulated wild-type Kit that underwent coimmunoprecipitation with the lipid kinase, the dimerizationdefective A4 protein was unable to undergo coupling to PI3K after stimulation with SCF. This was demonstrated by either an in vitro PI3K assay of receptor immunoprecipitates (Figure 5a ) or by Western blotting with anti-PI3K antibodies (Figure 5b ). We next investigated the ability of the dimerization-defective receptor mutant to induce a change in intracellular Ca 2+ concentration by using the Ca2+-sensitive fluorophor Fura2-AM. Dye-loaded cells that overexpressed either wild-type Kit or &4 were incubated with SCF, and intracellular Ca 2+ concentrations were monitored. Whereas a rapid increase in Ca 2+ concentration that peaked at 10-15 s was observed in Kit-expressing cells, no change took place in A4-expressing cells (Figure 5c ), even after longer incubation and with higher ligand concentrations (up to 300 ng/ml; data not shown). For control, we incubated the serum-starved cells with fetal calf serum (5% FCS) and observed similar Ca 2+ mobilizations in both cell lines, indicating that they differed in the response to SCF but not in response to other factors.
To demonstrate the requirement of receptor dimerization and tyrosine kinase activation for long-term actions of SCF, we used the dimerization-inhibitory MAb and the SCF-dependent myeloid cell line TF-I. The cells were first starved for serum factors and were then incubated with SCF in conditions under which the factor maintained their viability and proliferation. Coincubation of the cells with SCF and increasing concentrations of MAb K27 resulted in gradual inhibition of DNA synthesis, as measured by the incorporation of [3H-methyl]thymidine into macromolecules ( Figure 6A ). More extensive inhibition was induced bythe ligand-competitory MAb K44, which, like K27, inhibited receptor phosphorylation (see Figure 4A) . Consistent with the necessity of receptor dimerization for the effect of SCF on cell cycle regulation, no increase in DNA synthesis was observed in SCF-stimulated murine fibroblasts that expressed the dimerization-defective A4 receptor ( Figure  6B ). By contrast, fibroblasts that expressed the wild-type receptor displayed a bell-shaped dose-response curve. Taken together, the results depicted in Figures 5 and 6 implied that receptor dimerization is essential for both short-and long-term biological effects of SCF.
Inhibition of Receptor Dimerization Reduces SCF Binding Affinity by Accelerating Ligand Dissociation
The relationships between ligand binding affinity and dimerization of receptor tyrosine kinases are presently unclear. To address this question in the Kit-SCF system, we examined the effect of inhibition of receptor dimedzation on SCF binding affinity by using either a MAb or a dimeriza- were incubated in the absence (minus sign) or presence (plus sign) of SCF (100 ng/ml). After 10 min at 37°C, cell lysates were prepared, and the Kit protein was subjected to immunoprecipitation. Washed immunocomplexes were assayed in vitro for associated PI3K activity as described (Lev et al., 1992a) , and the reaction products were separated using thin layer chromatography. Shown is an autoradiogram of a portion of the thin layer plate that corresponds to the location of phosphatidylinositol 3'-phosphate (PIP). Mr, relative molecular weight.
(b) Cells were treated with SCF (absence of SCF, minus sign; addition of SCF, plus sign), and lysates were immunoprecipitated as in (A). The immunocomplexes were subjected to gel electrophoresis, which was followed by Western blot analysis with an anti-PI3K antibody. The 85 kDa band corresponds to the regulatory subunit of PI3K, whereas the lower protein bands represent the heavy chain of the antibody used for immunoprcipitation. Mr, relative molecular weight. (c) Representative computerized images of factor-treated cells that expressed wild-type Kit protein (WT) or a domain 4-deleted mutant (A4). Fura2-AM-loaded cells were stimulated with SCF (100 ng/ml) or FCS (5%), or they were left untreated (CONTROL). Images were taken 12 s after stimulation. The pseudoimage colors represent increasing concentrations of Ca 2÷. The experiment was repeated three times.
tion-defective receptor. Ligand saturation curves showed that both means of inhibition of receptor dimerization resulted in a significant reduction in SCF binding ( Figures  7A and 7C, see insets) . Analysis of the binding data according to the method of Scatchard (Scatchard, 1949) revealed that this was due to a reduction in receptor affinity. Whereas treatment with the dimerization-inhibitory antibody resulted in a linear Scatchard plot that indicated reduced affinity and partial disappearance of binding sites ( Figure 7A ), the dimerization-defective receptor displayed a curvilinear Scatchard plot ( Figure 7C ). This may be due to negative cooperativity or to the existence of two receptor populations, a minor population (KD = 0.2 nM) and a major class, that corresponded to approximately 90% of the binding sites and affinity of which (KD --3.5 nM) was comparable with that observed when receptor dimerization was inhibited by MAb K27. Ligand affinity is determined by the rates of ligand association and dissociation under equilibrium conditions. Therefore, we addressed the question regarding which of these processes was responsible for the presumed increased affinity of receptor dimers. Ligand association analysis showed that inhibition of receptor dimerization by using either MAb K27 or domain 4-deleted receptor did not result in significant changes in kon values. By contrast, the extremely slow rate of ligand dissociation from Kit was dramatically increased by MAb K27 (ko, = 2.7 x 10-5/s; Figure 7B) . Similarly, the dimerization-defective mutant released the ligand at a comparable rate (ko, = 2.8 x 10-~/s), and this effect was enhanced when the overall rate of SCF dissociation was increased by the addition of unlabeled ligand to the dissociation medium ( Figure  7D ). In conclusion, the observed reduction in SCF binding affinity upon inhibition of dimer formation by two independent methods was due to an increase in the rate of ligand dissociation.
Discussion
Ligands of receptor tyrosine kinases are either monomeric (e.g., EGF) or dimeric (e.g., PDGF), and, therefore, they are expected to be monovalent or bivalent. Nevertheless, both types of ligands induce rapid dimerization of their respective receptors, suggesting that bivalency is not essential for forming receptor dimers. This paradigm was supported by our observation that human and mouse Kit proteins form heterodimers upon binding of the humanspecific ligand (Lev et al., 1992b) . On the basis of this and other lines of evidence, we proposed a sequential model that attributes receptor dimerization to a putative intrinsic receptor site, which undergoes conformational "opening" consequent to ligand binding. Recent studies appear to support this model. Monovalent interactions of PDGF with its receptor (Herren et al., 1993 ) and a monomeric CSF-1 molecule (Krautwald and Baccarini, 1993) were found to be biologically active. The observation that a soluble Kit (B) Murine fibroblasts that expressed either wild-type Kit (squares) or a domain 4-deletion mutant (circles) were grown in 24-well culture dishes. Different concentrations of SCF were added after 2 days of serum starvation, and incubation was continued for 43 hr, followed by a 5 hr pulse with [3H-methyl]thymidine (5 ~.Ci/well). Acid alcohol precipitable radioactivity was determined in triplicates. Scale bars indicate standard deviations.
protein that lacked the C-terminal two immunoglobulin-like domains lost its ability to undergo ligand-induced dimerization (Figure 3 ) further supported the notion that ligand bivalency is insufficient for receptor dimerization. The ability of the fourth immunoglobulin-like domain to confer ligand-dependent dimerization to both soluble ( Figure 3A ) and transmembrane ( Figure 3B ) Kit proteins and epitope mapping of a dimerization-inhibitory MAb to this domain ( Figure 2B ) identified immunoglobulin domain 4 as the intrinsic receptor dimerization site. It is interesting that in the related receptor for CSF-1, namely Fms, several oncogenic mutations that activate tyrosine phosphorylation by stabilizing receptor dimers were mapped to the fourth domain of this receptor (Carlberg and Rohrschneider, 1994) . In both Fms and Kit, the fourth immunoglobulin-like domains lack the characteristic intradomain S-S bond.
Receptor Dimerization Is Driven by the Rate of Ligand Dissociation
The availability of a dimerization-inhibitory MAb and a dimerization-defective Kit enabled us to directly address the currently open causative relationships between ligand binding and receptor dimerization. Monomeric Kit proteins displayed reduced affinity to SCF under equilibrium conditions when their conversion to dimers was prevented by a MAb or by deletion of the intrinsic dimerization site (Figure 7) . In addition, we noted an apparent limited decrease in receptor numbers. Unlike MAb-treated Kit, domain 4-deleted receptors clearly exhibited a curvilinear Scatchard plot. This negative curvature is characteristic of other types of receptors (e.g., EGF receptor), and it may suggest that SCF binding to monomers is negatively cooperative. Otherwise, it may reflect receptor heterogeneity, which does not exist in the presence of MAb K27. Independent of the exact interpretation, the results of the ligand binding analyses strongly suggest that dimerization of Kit is driven by the higher ligand affinity of receptor dimers as compared with that of receptor monomers. Further analyses ( Figure 7B and 7D) identified the rate of ligand release from the receptor as the cause of the affinity differences. Evidently, forcing receptor monomerization accelerated the rate of SCF dissociation. An almost inevitable model would then attribute ligand-induced dimerization of Kit to an equilibrium between receptor monomers and dimers, of which the former forms predominate. Apparently, SCF associates at the same rate with both monomeric and dimeric forms, but it is retained by receptor dimers for a significantly longer time. This probably translates into shifting the equilibrium toward receptor dimers. The validity of this model and its relevance to other growth factor receptors is supported by several lines of evidence. For example, it has been previously shown that an oncogenic mutation that constitutively maintains dimers of the Neu/ ErbB2 receptor (Weiner et al., 1989) increased ligand affinity by slowing the rate of ligand dissociation (Ben-Levy et al., 1992) .
Structural Features of the Fourth Immunoglobulin-like Domain of Kit
The observation that the dimerization site of Kit is limited to a single immunoglobulin-like domain is in contrast with the noncontiguous and extended nature of the SCFbinding site Lev et al., 1993) . Since no higher order oligomers of Kit were observed and because we mapped only one dimerization site on Kit, it seems likely that this site is monovalent and is symmetrically located on the dimerized molecules. These principles prevail in the dimeric structure of immunoglobulin-related molecules (Williams and Barclay, 1988) . The fourth domain, however, is unique in that it lacks the intradomain disulfide bond. Nondisulfide-linked immunoglobulin-like domains exist in several immunoglobulin-related molecules, such as the major histocompatibility complex antigens, ~2-microglobulin-associated antigens, domain 3 of the CD4 molecule (Brady et al., 1993) , and domain 1 of the CD2 molecule (Jones et al., t 992) . The corresponding portions of these molecules often display higher structural flexibility, which in the case of Kit may permit its regulability by ligand binding. Despite the absence of the hallmark two cysteine residues, the seven I} strands of Fc domains are readily recognizable in the primary structure of the fourth immunoglobu- Figure 7 . AnalysesofSCFBindingto Kitinthe Absence of Receptor Dimerization (A) The effect of a dimerization-inhibitory MAb on ligand binding. Murine fibroblasts (approximately 1 x 10 s cells) that overexpressed the human Kit protein were incubated with increasing concentrations of radiolabeled human SCF in the presence of 10 l~g/ml MAb K49 (squares) or MAb K27 (circles). Following 3 hr at 4°C, the cell monolayers were extensively washed, and the remaining radioactivity was determined. The results are presented as saturation curves (insets) or as Scatchard plots. Each data point represents the average of a duplicate determination. Nonspecific ligand binding, which was determined in the presence of a 100-fold excess of unlabeled SCF, was subtracted from the total amount of cell-bound SCF. (B) Dissociation kinetics. Radiolabeled SCF (50 ng/ml) was incubated for 3 hr at 4°C with 1 x 105 cells that overexpressed human Kit. Following a brief washing step at 4°C, the cells were incubated with the following MAbs (10 p.g/ml): K49 (squares), K27 (circles), or K44 (triangles). The amount of ligand that was dissociated from the cells was determined at various time intervals, and nonspecifically bound radioactivity was subtracted from it. The data were analyzed according to a previously described method (Berkers et al., 1991) . Accordingly, Bt is the amount of ligand that remained bound at time t of dissociation, and Bo is the amount of ligand that was bound before dissociation was allowed. Each data point represents the average of a duplicate determination. (C and D) Analyses of ligand binding to a dimerization-defective receptor. Monolayers of murine fibroblasts that expressed either a wild-type Kit protein (squares) or a domain 4-deletion mutant (circles) were analyzed by using radiolabeled SCF exactly as described in (A) and (B), respectively. Shown are Scatchard plots (C) together with the corresponding saturation curves (insets) and dissociation curves (D). The latter analysis was performed in the absence (closed symbols) or presence (open symbols) of unlabeled SCF (100 ng/ml). Each data point is the average of a duplicate determination.
lin-like domain. Specifically, strands B, C, and F display hydrophobic residues in alternating positions and other anchoring amino acids, while strands A and G, which do not contain conserved residues, are harder to identify. These I~ strands are separated by six loops, three of which contain potential asparagine-linked glycosylation sites. Remarkably, several canonical amino acids, including a tryptophan residue (numbered 358 in the human Kit) and an upstream proline residue in the B-C loop, match the consensus of the C1 set of immunoglobulin-related domains. Overall, the primary structure best matches the requirements of the C2 set and to a lesser extent those of the C1 set. Since no crystal structures are available for proteins that belong to the C2 set, we based our structural model on the structures of the constant domains, CH2 and CH3, of the human Fc fragment (Deisenhofer, 1981) . This was followed by several steps of energy minimization, which yielded a typical 13 sheet structure with a hydrophobic interior. The predicted intersheet distance was larger than that in the Fc and Fv domains because the conserved cysteine residues were replaced by hydrophobic side chains. This result is supported by the crystal structure of domain 3 of CD4 (Brady et al,, 1993 ). The energy-minimized model of domain 4 was superimposed by best molecular fit onto the two domains forming the CH3 dimer of the human Fc fragment. The resulting model dimer is depicted in Figure 8 . The predicted interface between the domains has a mixed hydrophobic and electrostatic nature. Four pairs of hydrophobic side chains (shown in blue in Figure  8 ) are found in the core of the interface. This patch is flanked on both sides by 10 charged or polar residues The ribbon diagram of the peptide backbones of the domains is viewed from the C-terminal side. To discriminate between the monomers, each is shown with a different color (gray or green). Only the peptide backbone is shown, except for the interdomain interface, at which atoms of the side residues are shown in blue (hydrophobic residues that comprise a hydrophobic patch) or pink (hydrophilic residues that flank the hydrophobic patch). The N-and C-termini of each monomer are indicated. The locations of the three pairs of asparagine residues, which are presumably linked to sugar residues, are shown in red. Note that each monomer has a characteristic core, which is delineated by I~ sheets.
(shown in pink in Figure 8 ). An important outcome of this model structure is the estimation of its stability in comparison to other dimers of immunoglobulin domains. Due to the presence of several salt bridges and a larger hydrophobic core, monomer-monomer interactions in ordinary immunoglobulin molecules are significantly more stable than the predicted dimer of domain 4. Remarkably, domain 4 dimers are held together predominantly by electrostatic rather than by hydrophobic interactions, and since these can be replaced by monomer-solvent interactions, the expected stability of domain 4 dimers is low in comparison to the constitutive dimers of immunoglobulin molecules.
At present, the exact mode of induction of receptor dimers remains open. Another unanswered question relates to the molecular mechanism that couples ligand binding to dimer formation. Possibly, intramolecular conformational changes and interactions with the fifth immunoglobulinlike domain, the role of which is presently unknown, are involved. Nevertheless, similar intrinsic sites may exist in other receptor tyrosine kinases. Moreover, receptors that contain immunoglobulin-like blocks in their ectodomains outnumber receptors with other structural motifs. Therefore, the observations described here for domain 4 of Kit may be relevant to other growth factor receptors.
Experimental Procedures
Materials and Antibodies
Radioactive materials were purchased from Amersham Corp. Polyclonal antibodies to human Kit/SCF receptor were raised in rabbits that were injected with a recombinant Kit-X protein or with a 14 amino acid synthetic peptide that corresponds to the C-terminal tail of the human Kit protein (Ab 212). MAbs directed against the extracellular domain of human Kit were generated and purified as has been previously described . A rabbit antibody to PI3K was prepared against a synthetic peptide containing the COOHterminal 15 amino acids of human p85~ (Lev et al., 1992a) . Radiolabeling of SCF, biosynthetic labeling, Western blotting, and the compositions of buffered solutions were as previously described .
Construction and Expression of Kit 1-2-3-4
To express Kit 1-2-3-4, we used a previously described plasmid that contained the cDNA of the full-length ectodomain of Kit (Lev et al., 1992c) . A 265 bp SphI-Clal segment that encoded the fifth immunoglobulin-like domain was removed the Clal site was treated with Klenow DNA polymerase, and the Sphl site was treated with T4 DNA polymerase. The resulting blunt ends of the plasmid were religated. This placed four additional codons that code for arginine, leucine, valine, and isoleucine downstream of the codon of asparagine residue 423 of human c-kit, followed by an in-frame stop codon. A 1304 bp BamHI-Xbal fragment was then isolated from the plasmid and was inserted into the pcDNAI-NEO expression vector (Invitrogene). Transfectants were selected in medium containing gentamycin (0.8 mg/ml), and single-cell colonies were selected.
Construction and Expression of Domain 4-Deleted Kit Protein
To construct a cDNA that directs expression of a Kit protein lacking the fourth immunoglobuiin-like domain (A4), we used a previously described mutant of c-kit in which a Kpnl site was introduced into the cDNA portion that codes for the region between domains 3 and 4 (at nucleotide number 910). The mutant gene, in a Bluescript vector, was cut with Kpnl and Bglll (nucleotide position 2240) to yield a 1330 bp fragment. Two DNA fragments were then amplified by using polymerase chain reaction (PCR) and the isolated KpnI-Bglll fragment: The first amplified piece of DNA was 78 bp long and corresponded to residues 910-988 of c-kit. The following oligonucleotides were used as primers: 5'-GGTGGTACCGCAAATGTC-3' and 5'-GGCAGCATTGACGTCCGTAGTGGTTATCATGGG-3'. The second amplified DNA fragment was 1026 bp long and corresponded to nucleotides 1214-2240. The sequences of the oligonucleotide primers were as follows: 5'-GACGTCAATGCTGCCATAGC-3' and 5'-CACAGATC-TCC I I I I GTCGG-3'. Both fragments were purified from agarose gels, denatured, annealed, and filled in with Klenow enzyme. The region of complementarity is indicated by an underline in the corresponding sequences of the oligonucleotide primers. The annealed and extended DNA fragment was used as a template for PCR amplification by using the following oligonucleotide primers: 5'-GGTGGTACCGCAAATGTC-3' and 5'-CACAGATCTCCTITTGTCGG-3'. The amplified DNA fragment was cleaved with Bglll and Kpnl and was inserted into the original c-kit-containing Bluescript plasmid. The integrity of the open reading frame was confirmed by nucleotide sequencing, and the mutated DNA was introduced into a mammalian expression vector. Murine NIH 3T3 fibroblasts were cotransfected with the constructed expression vector and pSV2neo. Single-cell clones were selected by growth in gentamicin-containing (0.8 mg/ml) medium, and overexpressors were selected by using a binding assay with radiolabeled SCF.
Thymidine Incorporation Assays
Murine fibroblasts that overexpress either wild-type Kit or a domain 4-deleted mutant (A4) were grown to 80% confluence in 24-well dishes that were coated with 10 p~g/ml of human plasma fibronectin in phosphate-buffered saline (PBS). Cells were starved for 48 hr in DME medium containing 0.1% of FCS, and then SCF was added. The cells were further incubated for 48 hr at 22°C. [3H-methyl]thymidine (5 llCi/ well) was added for the last 5 hr of incubation, and acidic alcoholprecipitable radioactivity was determined. Each data point is the average of a triplicate determination. Alternatively, TF1 cells were grown as a suspension culture in RPMI 1640 medium supplemented with 10% FCS and 2 ng/ml of recombinant human GM-CSF until the ceils reached a concentration of 1 x 108 per milliliter. Growth factor deprivation was achieved by washing the cells twice in RPMI 1640 medium. Cells were seeded at 10,000/well in 96-well plates and preincubated for 2 hr with or without the indicated concentrations of various MAbs, and then human SCF (5 ng/ml) was added. Following 48 hr of incubation, [3H-methyl]thymidine was added (1 ~Ci/well) for the last 4 hr. Cells were harvested using a cell harvester (PHD, Cambridge Tech), and radioactivity was determined by liquid scintillation counting.
Assay of Intracellular Ca 2. Mobilization
Cells were plated on 25 mm coverslips at a density of 8 x 104 cells per coverslip. Following 48 hr of culturing in DME medium with 5% FCS, the medium was replaced with the same medium containing 0.5% FCS for 16 hr. The cells were maintained in the starvation medium without phenol red for an additional 2 hr before loading them with 2 ~M Fura2-AM for 1 hr. Excess dye was removed by washing the monolayers three times (2 ml each time) with the same medium, which had no serum. The coverslips were then mounted in a 25 mm chamber and were treated with SCF or FCS at 22°C as indicated. The fluorescence at wavelength 510 nm was monitored by using excitations at 340 nm and 380 nm (MacCumber et al., 1990) . The ratio between the images at 340 nm and 380 nm was obtained with a computerized video imaging system (Biological Detection Systems), and the relative intracellular Ca b levels were determined.
Covalent Cross-Linking of SCF to Kit Proteins
Confluent monolayers of Kit-expressing cells were grown in 65 mm diameter plates. The cells were first washed with PBS and then were incubated with or without different MAbs in the presence of radiolabeled SCF (20 ng of human SCF per milliliter). After 90 rain at 4°C, the plates were transferred to 22°C and either 1-ethyl-3-(3-dimethylaminopropyl)-carbodiimide (EDAC) (15 raM), disuccinimidyl suberate (DSS), or bis(sulphosuccinimidyl) suberate (BS 3, Pierce Biochemical) was added to a final concentration of 0.5 raM. The cross-linking reaction was terminated by extensive washing with PBS, followed by 5 min of incubation with PBS containing 150 mM glycine-HCI buffered at pH 7.5. To examine SCF binding to soluble Kit proteins, the affinitypurified proteins were incubated in PBS together with 1251-SCF (100 ng/ml, 1 x 105 cpm/ng) in the presence of unlabeled SCF (1 p.g) or transforming growth factor (~ (TGF0q 0.5 p.g). The total reaction volume was 0.06 ml. After 4 hr at 22°C, the proteins were subjected to covalent cross-linking by adding DSS to 0.5 mM final concentration, and the reaction was allowed to continue for an additional 40 rain at 22°C. Gel sample buffer was then added, and the reaction was terminated by boiling and SDS-PAGE.
Nondenaturing Polyacrylamide Gel Analysis
Determination of molecular weights using nondenaturing polyacryiamide gel was carried out as previously described (Amster-Choder and Wright, 1992) . Kit-X and Kit 1-2-3 proteins that were affinity puri~fied by using a MAb to Kit were incubated with radiolabeled SCF in 0:02 ml of 10 mM Tris-HCI (pH 8.3). Following 2 hr at 22°C, gel sample buffer was added (10 mM Tris [pH 6.7], 16% glycerol, 0.04°/0 bromophenol blue). The mixtures were analyzed on native gels contaiging 50,6%, 7%, 8%, 8.5%, and 9% acrylamide side by side with standard markers (Pharmacia). Electrophoresis was stopped when the dye reached the bottom of the gel. The molecular size markers were revealed by Coomassie blue staining, and the ligand-complexed Kit proteins were revealed by autoradiography.
SCF Binding Analysis
Ligand binding analyses were performed as described . Ligand association was analyzed by incubation of cell monolayers with radiolabeled SCF (30 ng/ml) in 0.2 ml of binding buffer at various time intervals on ice. The monolayers were then [apidly washed twice with 1 ml of ice-cold binding buffer and dissolved in 0.1 N NaOH plus 0.1% SDS, and the radioactivity was determined. Duplicate determinations were performed. The nonspecific binding that was determined in the presence of a 100-fold excess of unlabeled SCF was subtracted, and the association data were analyzed by determination of the amount of ligand bound at full saturation (B=). The ratio of ligand bound at time t (Bt) to B= was then calculated and described as a function of time. For ligand dissociation analysis, cell monolayers were allowed to bind radiolabeled SCF (30 ng/ml) for 2 hr on ice. After a rapid wash with binding buffer, the cells were incubated for various periods of time with 0.25 ml of binding buffer, with or without unlabeled SCF or certain MAbs. The amount of cell-bound ligand at the end of the ligand dissociation experiment was determined after washing twice with PBS. Duplicate determinations were performed, and the nonspecific binding was separately quantitated for each time point.
Model Building of Immunoglobulin-like Domain 4 of Kit
Model building was preceded by alignment of the amino acid sequences of human domain 4 with domains CH2 and CH3 of human Fc fragment (Deisenhofer, 1981 ). An initial model was built in analogy to the CH2 domain (Protein Data Bank entry 1FC1). Residues were replaced using the interactive graphics program FRODO (Jones, 1978) . The initial model was subjected to several steps of energy minimization using the program ENCAD (Levitt, 1983) . The positions of all Ca atoms were initially restrained, and loop regions were subjected to 50,000 steps of dynamics at 300K (at one femtosecond per step and 50 ps on the whole) with intermittent energy minimizations. The sheet framework residues were kept fixed at this stage, The torsion angles of several residues at the ends of the ~ sheets deviated from values dictated by the Ramachandran plot (Ramachandran and Sassiekharan, 1968) . In a subsequent dynamics and minimization run (50 ps, 300K), these residues were free to move together with the residues of the loops. This resulted in considerable improvement in their geometry without disrupting the ~ sheet framework. To construct a model of a dimer of domain 4, the energy-minimized model of this domain was superimposed by best molecular fit onto the two domains forming the CH3 dimer in the human Fc fragment. Only the Ca atoms of the conserved cysteine and tryptophan residues and the amino acids that flank them at both sides were used to determine the transformation matrix and vector. The resulting calculated energy of domain 4 dimers was -1536 kcal/mol, whereas the calculated energy of the CH3 dimer was -1598 kcal/mol.
